The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line bosutinib (BOS) for patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML): Final 10-year results of a phase 1/2 study.
 
Carlo Gambacorti-Passerini
Honoraria - Pfizer
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Pfizer
 
Tim H. Brümmendorf
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Janssen; Merck; Novartis; Pfizer
Research Funding - Novartis; Pfizer
 
Dong-Wook Kim
Research Funding - Pfizer
 
Yeow Tee Goh
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Takeda
Consulting or Advisory Role - Amgen; Antengene; EUSA Pharma; Gilead Sciences; Janssen; Pfizer; Roche
Research Funding - Pfizer
 
Irina S Dyagil
Research Funding - Pfizer
 
Katia Pagnano
Honoraria - Astellas Pharma; EMS; Janssen; Novartis; Pint Pharma
Consulting or Advisory Role - Abbvie; GlaxoSmithKline; Novartis; Sandoz
 
Arpad Batai
Research Funding - Pfizer
 
Anna G. Turkina
Consulting or Advisory Role - Fusion Antibodies; Novartis; Pfizer
Research Funding - Pfizer
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Simon Purcell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jocelyn M Leone
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrea Viqueira
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)